Category: Latest News

Enhabit Inc. (NYSE:EHAB) shares surged more than 22% in premarket trading Monday after the home health and hospice provider announced a definitive agreement to be acquired by private equity firm Kinderhook Industries in an all-cash deal valued at roughly $1.1 billion. Under the terms of the agreement, Enhabit shareholders will receive $13.80 per share in…

Psyence Biomedical Ltd. (NASDAQ:PBM) shares climbed 4.4% in premarket trading Monday after the company announced plans to acquire an equity stake in Psyence Labs Ltd. through a share-for-share transaction. The deal comes after Psyence Labs exercised a previously disclosed put option. Under the agreement, Psyence Biomedical will acquire 2,900 Psyence Labs shares, representing a total…

MoonLake Immunotherapeutics (NASDAQ:MLTX) shares advanced 6.6% in premarket trading Monday after the company reported positive topline findings from its Phase 2 S-OLARIS study evaluating sonelokimab for axial spondyloarthritis (axSpA). According to the company, 81% of patients receiving sonelokimab achieved an ASAS40 response at Week 12, indicating at least a 40% improvement across key disease measures.…

Vertical Aerospace Ltd. (NYSE:EVTL) shares declined 2.7% in premarket trading Monday after Raymond James lowered its rating on the stock from Market Perform to Underperform, citing financial and competitive concerns. Raymond James analyst Savanthi Syth pointed to uncertainty surrounding the company’s funding runway and increasing competition within the electric aviation sector. The analyst estimates Vertical…

Axsome Therapeutics Inc. (NASDAQ:AXSM) reported fourth-quarter results that topped analyst forecasts, although the company’s shares fell 2.03% in premarket trading following the announcement. The biopharmaceutical company posted a quarterly loss of $0.56 per share, outperforming the consensus expectation for a loss of $0.73 per share. Revenue for the quarter came in at $196.0 million, exceeding…

ImmunityBio, Inc. (NASDAQ:IBRX), a commercial-stage immunotherapy company, disclosed significant financial and operational progress for 2025 in a newly filed SEC Form 8-K, highlighting sharp revenue growth, expanding product approvals and advancing international partnerships. Financial Performance The company reported full-year net product revenue of $113 million for 2025, representing an approximately 700% increase compared with the…

Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) said it is in advanced, final-stage discussions regarding a potential strategic business combination with a leading insurance technology company operating across the Asia-Pacific region. The company also confirmed it continues to advance its previously announced strategy to acquire Bitcoin (BTC), part of a broader effort aimed at strengthening long-term shareholder…

Fortress Biotech, Inc. (NASDAQ:FBIO) said its majority-owned subsidiary Cyprium Therapeutics has signed a definitive agreement to sell a Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $205 million, marking a significant monetization event following the recent FDA approval of ZYCUBO®. The voucher was granted after the U.S. Food and Drug Administration approved…

Gossamer Bio (NASDAQ:GOSS) shares dropped roughly 80% on Monday after the company announced that its investigational therapy seralutinib failed to achieve the primary endpoint in the Phase 3 PROSERA study targeting pulmonary arterial hypertension (PAH). The trial reported a placebo-adjusted improvement in Six-Minute Walk Distance (6MWD) of 13.3 meters at Week 24, with a p-value…

Atomera Incorporated (NASDAQ:ATOM) shares dropped 15% on Monday after the company disclosed plans for a $25 million registered direct offering of common stock. The semiconductor materials and technology licensing firm said it has entered into a securities purchase agreement with institutional investors to sell 5,000,000 shares priced at $5.00 each. The transaction is expected to…